Special 3/2013

  • Intellectual Property

    In this spezial issue:

    • Bio-IP experiencing continental drift
    • Interview with Taros Chemicals "A blueprint for future drug development"
    • Substance Protection - Hands off gene patents!
    • Out-licensing in the life sciences sector

Volume 2014

Volume 2013

Volume 2012

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/magazine/spezial/2013/3/pos/1.html?cHash=bfd90e2d54056358af1b4a091bcb4f71&sort=asc

Kurszettel

Alle Kurse

TOP

  • LONZA107.50 CHF3.46%
  • MORPHOSYS72.46 EUR2.96%
  • SANTHERA95.00 CHF2.48%

FLOP

  • 4SC1.18 EUR-4.07%
  • CYTOS0.25 CHF-3.85%
  • BIOFRONTERA2.32 EUR-3.33%

TOP

  • SANTHERA95.00 CHF58.6%
  • EPIGENOMICS3.72 EUR16.2%
  • BB BIOTECH147.00 EUR13.6%

FLOP

  • BIOFRONTERA2.32 EUR-13.4%
  • WILEX2.36 EUR-12.6%
  • MEDIGENE4.30 EUR-11.3%

TOP

  • SANTHERA95.00 CHF3715.3%
  • CO.DON2.46 EUR207.5%
  • PAION2.41 EUR153.7%

FLOP

  • CYTOS0.25 CHF-93.7%
  • THERAMETRICS0.08 CHF-42.9%
  • MERCK KGAA66.45 EUR-42.3%

No liability assumed, Date: 02.09.2014